Tianjin Ringpu to acquire additional 18.2% stake in Hubei Longxiang

About This Report

Abstract:

Tianjin Ringpu Bio-technology Co., Ltd., a biotechnology company focused on the research, development, production and sale of biological products, is planning to acquire an additional 18.2% stake in Hubei Longxiang Pharmaceutical.

Following terms and conditions apply: All charges are made in USD. Actual charge to your credit card may deviate due to the currency exchange and Bank fees from your financial institution as some banks and credit cards impose fees for international transactions outside the United States. If you have any questions about these fees or the exchange rate applied to your booking, please contact your bank.